Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Warts are common and infectious viral diseases of the skin and are prevalent worldwide. Warts are caused by the human papilloma virus (HPV), which has more than 100 strains; some of them are known to be premalignant .Although warts can appear at any age, they are more common in children and adolescents. The prognosis of warts cannot be predicted. In some patients they may spontaneously disappear, whereas others show persistence and progression with spreading to other body sites, leading to physical and emotional distress to the patients. [ 1 ].

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Zinc; Zinc Sulfate

Criteria

Inclusion Criteria:- patients with ages ranging from 10 to 40 years with cutaneous common or planter wart ,

• or were either resistant to treatment

• or had relapsed at least once after treatment with any of the tissue-destructive modalities

Exclusion Criteria:.- Patients with any evidence of immunosuppressant,

• eczematous skin disorder,

• those with any history of hypersensitivity to Candida albicans antigen,

• pregnant or lactating women,

• and those who received any wart treatment 1 month before the start of the study will be excluded from the study